Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,694 | -26,934 | -116,426 | -88,941 | -58,676 |
| Depreciation Amortization | 417 | 192 | 741 | 567 | 416 |
| Accounts receivable | 32 | 26 | -64 | 29 | -68 |
| Accounts payable and accrued liabilities | -1,979 | 3,403 | 2,122 | 3,785 | 2,257 |
| Other Working Capital | -5,635 | 6,134 | 9,493 | 14,420 | 17,713 |
| Other Operating Activity | 10,572 | 779 | 12,877 | 7,333 | 5,209 |
| Operating Cash Flow | $-41,287 | $-16,399 | $-91,257 | $-62,807 | $-33,150 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -103 | -29 | -49 | -49 | -40 |
| Purchase Of Investment | -206,035 | -101,945 | -395,757 | -320,098 | -182,229 |
| Sale Of Investment | 228,142 | 93,104 | 488,069 | 410,733 | 219,884 |
| Investing Cash Flow | $22,004 | $-8,870 | $92,262 | $90,585 | $37,615 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 125,000 | 125,000 | N/A |
| Common Stock Issued | 231 | 224 | 478 | 450 | 348 |
| Other Financing Activity | 0 | 0 | -125,000 | 0 | 0 |
| Financing Cash Flow | $231 | $224 | $478 | $125,450 | $348 |
| Beginning Cash Position | 48,642 | 48,642 | 47,159 | 47,159 | 47,159 |
| End Cash Position | 29,591 | 23,598 | 48,642 | 200,388 | 51,973 |
| Net Cash Flow | $-19,052 | $-25,044 | $1,483 | $153,229 | $4,814 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,287 | -16,399 | -91,257 | -62,807 | -33,150 |
| Capital Expenditure | -103 | -29 | -49 | -49 | -40 |
| Free Cash Flow | -41,390 | -16,427 | -91,306 | -62,856 | -33,190 |